drugset / Trial / NCT02254629

The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients

NCT02254629

Phase 1 Completed 56 enrolled Shandong University
RandomizedParallel-groupOpen-labelTreatment

Summary

the laxative-probiotic sequential treatment might reduce the symptoms of IBS and alter the fecal microbiota of the patients in a more robust manner .

Timeline

Start
2014-07
Primary completion
2015-08
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Clostridium butyricum Other / unclassified 2 unknown
Subject polyethylene glycol Other / unclassified 2000 ml